Uudised

Genomic risk assessment with Oncotype DX in young women (age≤ 40 years old) with early-stage ER+/HER2-/N0 breast cancer

R. Iosifidou, G. Xepapadakis, V. Venizelos, C. Markopoulos, K. Papazisis, N. Tsoulos, G. Kapetsis, S. Giannoulakis, M. Paraskeva, M. Kaparelou, G. Lainakis, A. Fotarelli, F. Pavlidou, E. Fountzilas, E. Saloustros, S. Karageorgopoulou, S. Triantafillidou, S. Intzes, F. Koinis